How we manage patients with hereditary haemochromatosis.
about
Hemochromatosis, Erythrocytosis and the JAK2 p.V617F Mutation.Excess iron: considerations related to development and early growth.Pathophysiology and treatment of patients with beta-thalassemia - an update.The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.
P2860
How we manage patients with hereditary haemochromatosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
How we manage patients with hereditary haemochromatosis.
@en
type
label
How we manage patients with hereditary haemochromatosis.
@en
prefLabel
How we manage patients with hereditary haemochromatosis.
@en
P2093
P2860
P356
P1476
How we manage patients with hereditary haemochromatosis.
@en
P2093
Eva Rombout-Sestrienkova
Ger H Koek
Marian G J van Kraaij
P2860
P304
P356
10.1111/BJH.14376
P407
P577
2016-10-10T00:00:00Z